The frequency of polycystic ovary syndrome in young reproductive females in Qatar

and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). International Journal of Women’s Health 2017:9 1–10 International Journal of Women’s Health Dovepress

[1]  M. Murad,et al.  Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. , 2018, The Journal of clinical endocrinology and metabolism.

[2]  S. Musmar,et al.  Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine , 2013, Reproductive Biology and Endocrinology.

[3]  E. Rey-Roldán,et al.  Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk? , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  J. Sreedharan,et al.  Biochemical Parameters in Women with Polycystic Ovary Syndrome in Ajman, UAE , 2012 .

[5]  C. Tzeng,et al.  Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. , 2011, Human reproduction.

[6]  F. Azizi,et al.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study , 2011, Reproductive biology and endocrinology : RB&E.

[7]  R. Azziz,et al.  Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. , 2010, Fertility and sterility.

[8]  R. Norman,et al.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.

[9]  R. Norman,et al.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. , 2009, Fertility and sterility.

[10]  C. Wijeyaratne,et al.  A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. , 2008, American journal of epidemiology.

[11]  E. Diamanti-Kandarakis,et al.  Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents? , 2007, Hormones.

[12]  H. Raff,et al.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. , 2007, The Journal of clinical endocrinology and metabolism.

[13]  Abdulmalik U. Bako,et al.  Polycystic ovary syndrome: An overview , 2005 .

[14]  Ricardo Azziz,et al.  Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. , 2005, Fertility and sterility.

[15]  G. Kovacs,et al.  Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[16]  E. Carmina.  Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. , 2004, Minerva ginecologica.

[17]  E. Reynolds,et al.  Polycystic ovary syndrome: a review for primary providers. , 2003, Primary care.

[18]  A. Balen,et al.  Polycystic ovary syndrome--a systemic disorder? , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[19]  R. Cobin,et al.  American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[20]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[21]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[22]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[23]  I. Salama,et al.  Hirsutism in the United Arab Emirates: a hospital study. , 1996, Postgraduate medical journal.

[24]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[25]  R. Kelishadi,et al.  The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. , 2011, Endokrynologia Polska.

[26]  R. Seneviratne,et al.  Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. , 2011, Human reproduction.

[27]  R. Sulimani,et al.  Hirsutism in Saudi females of reproductive age: a hospital-based study , 2008, Annals of Saudi medicine.

[28]  F. Geisthövel.  A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome. , 2003, Reproductive biomedicine online.

[29]  R. Azziz,et al.  Family history as a risk factor for the polycystic ovary syndrome. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.